ImageneBio, Inc. (IMA)
NASDAQ · Healthcare
ImageneBio, Inc. Operating Income 2020–2025
ImageneBio, Inc. annual/quarterly operating income history and growth rate from 2020 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- ImageneBio, Inc. operating income for the quarter ending September 30, 2025 was -26.6 M, a 1206.19% increase year-over-year.
- ImageneBio, Inc. operating income for the twelve months ending September 30, 2025 was -54.1 M, a 25.68% decrease year-over-year.
- ImageneBio, Inc. annual operating income for 2025 was -48.5 M, a 30.95% increase from 2024.
- ImageneBio, Inc. annual operating income for 2024 was -37.0 M, a 50.94% decrease from 2023.
- ImageneBio, Inc. annual operating income for 2023 was -75.4 M, a 6.36% increase from 2022.
- ImageneBio, Inc. annual operating income for 2022 was -70.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ImageneBio, Inc. Operating Income — FAQ
ImageneBio, Inc. (IMA) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is ImageneBio, Inc.'s operating income?
ImageneBio, Inc. (IMA) reported operating income of -$48M for fiscal 2025.
Where can I see IMA's operating income history?
The chart and table above show ImageneBio, Inc.'s operating income by year and by quarter, including the growth rate.